- RGEN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13G/A Filing
Repligen (RGEN) SC 13G/AREPLIGEN / EDDLEMAN ROY T ownership change
Filed: 13 Feb 25, 11:20am
SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549 |
SCHEDULE 13G |
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment
No. 7
)*
|
Repligen Corporation. (Name of Issuer) |
Common Stock, $.01 par value per share (Title of Class of Securities) |
759916109 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
![]() |
![]() |
![]() |
SCHEDULE 13G |
CUSIP No. | 759916109 |
1 | Names of Reporting Persons Roy T. Eddleman Living Trust | ||||||||
2 | Check the appropriate box if a member of a Group (see
instructions) ![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization UNITED STATES | ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 2,705,689.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) ![]() | ||||||||
11 | Percent of class represented by amount in row (9) 4.84 % | ||||||||
12 | Type of Reporting Person (See Instructions) OO |
SCHEDULE 13G |
CUSIP No. | 759916109 |
1 | Names of Reporting Persons Roy T. Eddleman Charitable Remainder Trust #1 | ||||||||
2 | Check the appropriate box if a member of a Group (see
instructions) ![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization UNITED STATES | ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 441,818.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) ![]() | ||||||||
11 | Percent of class represented by amount in row (9) 0.79 % | ||||||||
12 | Type of Reporting Person (See Instructions) OO |
SCHEDULE 13G |
CUSIP No. | 759916109 |
1 | Names of Reporting Persons Roy T. Eddleman Charitable Remainder Trust #2 | ||||||||
2 | Check the appropriate box if a member of a Group (see
instructions) ![]() ![]() | ||||||||
3 | Sec Use Only | ||||||||
4 | Citizenship or Place of Organization UNITED STATES | ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 163,992.00 | ||||||||
10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) ![]() | ||||||||
11 | Percent of class represented by amount in row (9) 0.29 % | ||||||||
12 | Type of Reporting Person (See Instructions) OO |
SCHEDULE 13G |
Item 1. | ||
(a) | Name of issuer: Repligen Corporation. | |
(b) | Address of issuer's principal executive
offices: 41 Seyon Street, Waltham, Massachusetts 02453 | |
Item 2. | ||
(a) | Name of person filing: (i) Roy T. Eddleman Living Trust (Admin) UAD 8/17/2000
(ii) Roy T. Eddleman Charitable Remainder Trust #1
(iii) Roy T. Eddleman Charitable Remainder Trust #2 | |
(b) | Address or principal business office or, if
none, residence: c/o TroyGould PC, 1801 Century Park East, 16th Floor, Los Angeles, California 90067, Attention: Sherry Davaie. | |
(c) | Citizenship: Each reporting person was formed under the laws of the United States. | |
(d) | Title of class of securities: Common Stock, $.01 par value per share | |
(e) | CUSIP No.: 759916109 | |
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
(a) | ![]() | |
(b) | ![]() | |
(c) | ![]() | |
(d) | ![]() | |
(e) | ![]() | |
(f) | ![]() | |
(g) | ![]() | |
(h) | ![]() | |
(i) | ![]() | |
(j) | ![]() please specify the type of institution: | |
(k) | ![]() | |
Item 4. | Ownership | |
(a) | Amount beneficially owned: Roy T. Eddleman died on June 11, 2022. Mr. Eddleman was the sole trustee of each of the reporting persons, and as such had investment and voting control over such shares. Since Mr. Eddleman's death, Nereyda Rubio and Anis Garci have served as the co-trustees of each reporting person. As co-trustees, each co-trustee has investment and voting control over the shares covered by this Schedule and may be deemed to have shared voting power and shared investment power with respect to all such shares. The co-trustees disclaim beneficial ownership of each reporting persons' shares except to the extent of his/her pecuniary interest therein.
The percentage ownership information is calculated based upon 55,875,894 shares of common stock of the Issuer issued and outstanding as of September 30, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 18, 2024.
See Item 9 of the cover page. | |
(b) | Percent of class: See Item 9 of the cover page. % | |
(c) | Number of shares as to which the person has: | |
(i) Sole power to vote or to direct the vote: 0 | ||
(ii) Shared power to vote or to direct the
vote: 3,311,499. | ||
(iii) Sole power to dispose or to direct the
disposition of: 0 | ||
(iv) Shared power to dispose or to direct the
disposition of: 3,311,499. | ||
Item 5. | Ownership of 5 Percent or Less of a Class. | |
Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
Item 9. | Notice of Dissolution of Group. | |
Not Applicable
|
Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
SIGNATURE | |
After reasonable inquiry and to the
best of my knowledge and belief, I certify that the information set forth in this statement is
true, complete and correct. |
|
|
|
|
|
|
|
|
|